Autopsy report · NCT05788497

Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids

“Recruitment failure”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 9 months before it stopped.
• 21 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Faes Farma, S.A.

Sponsor type

Industry

Conditions

Haemorrhoids Without Complication

Interventions

Hemorrane plus; Hemorrane; Placebo

Participants

21

Sites

13

Countries

Spain

Trials that died the same way

• Measles Vaccine in HCW
  “Failure of subject recruitment” (87% match in meaning)
• Burden of Obstructive Sleep Apnea in Stroke (BOSAST)
  “problems with recruitment” (87% match in meaning)
• Use of IMSI in Poor Responders to IVF
  “DIfficulties with recruitment” (86% match in meaning)
• Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
  “Difficulties in recruitment” (86% match in meaning)
• Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in Oncology
  “Recruitment difficulties” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.